Soligenix receives UK medicine designation for Behcet's disease drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Soligenix receives UK medicine designation for Behcet's disease drug
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.39 -0.01 (2.5%)
Previous Close $0.40    52 Week High $4.35 
Open $0.40    52 Week Low $0.44 
Day High $0.41    P/E N/A 
Day Low $0.39    EPS $-0.81 
Volume 868,145